1 278

Cited 23 times in

The changes of estrogen receptor-β variants expression in breast carcinogenesis: Decrease of estrogen receptor-β2 expression is the key event in breast cancer development

DC FieldValueLanguage
dc.contributor.author김귀언-
dc.contributor.author김승일-
dc.contributor.author김주항-
dc.contributor.author박병우-
dc.contributor.author양우익-
dc.date.accessioned2015-06-10T11:53:54Z-
dc.date.available2015-06-10T11:53:54Z-
dc.date.issued2006-
dc.identifier.issn0022-4790-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/108820-
dc.description.abstractBACKGROUND AND OBJECTIVES: Although more than five variant forms of estrogen receptor-beta (ERbeta) have been identified, their role has not been identified. This study was carried out to investigate the changes of ERbeta variants in breast cancer development. METHODS: Using reverse transcription polymerase chain reaction (RT-PCR) and triple primer PCR (TP-PCR), the expression levels of ERbeta variants mRNA were measured in 66 paired normal and cancer tissues. The relative expression level of ERbeta variants were compared between normal and cancer tissues, and also compared according to various clinicopathological parameters. RESULTS: Among ERbeta variants, ERbeta2 and ERbeta5 consist of the major proportion of ERbeta expression both in normal and cancer tissues. The ERbeta and ERbeta2 expression levels decreased significantly in the cancers compared with corresponding normal tissues, particularly in ERalpha-expressing cancers. However, ERbeta5 expression level increased significantly in the cancers, especially in those of postmenopausal patients. The relative increase of ERbeta5 expression in cancer tissues was associated with favorable differentiation. CONCLUSIONS: Decrease of ERbeta2 is thought to be the key reason for the decrease in ERbeta expression in cancer tissues, and it is particularly associated with the development of ERalpha-expressing breast cancer.-
dc.description.statementOfResponsibilityopen-
dc.format.extent504~510-
dc.relation.isPartOfJOURNAL OF SURGICAL ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHBreast/metabolism-
dc.subject.MESHBreast Neoplasms/etiology*-
dc.subject.MESHBreast Neoplasms/genetics-
dc.subject.MESHBreast Neoplasms/metabolism*-
dc.subject.MESHBreast Neoplasms/pathology-
dc.subject.MESHEstrogen Receptor alpha/metabolism-
dc.subject.MESHEstrogen Receptor beta/genetics-
dc.subject.MESHEstrogen Receptor beta/metabolism*-
dc.subject.MESHEstrogen Receptor beta/physiology-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHPolymerase Chain Reaction-
dc.subject.MESHPostmenopause/metabolism-
dc.subject.MESHPremenopause/metabolism-
dc.subject.MESHRNA Splicing/genetics-
dc.subject.MESHRNA, Messenger/biosynthesis-
dc.subject.MESHRNA, Neoplasm/metabolism-
dc.subject.MESHReverse Transcriptase Polymerase Chain Reaction-
dc.titleThe changes of estrogen receptor-β variants expression in breast carcinogenesis: Decrease of estrogen receptor-β2 expression is the key event in breast cancer development-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorByeong-Woo Park-
dc.contributor.googleauthorKi-Suk Kim-
dc.contributor.googleauthorMin-Kyu Heo-
dc.contributor.googleauthorWoo-Ick Yang-
dc.contributor.googleauthorSeung Il Kim-
dc.contributor.googleauthorJoo-Hang Kim-
dc.contributor.googleauthorGwi Eon Kim-
dc.contributor.googleauthorKyong Sik Lee-
dc.identifier.doi10.1002/jso.20336-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00321-
dc.contributor.localIdA00658-
dc.contributor.localIdA00945-
dc.contributor.localIdA01475-
dc.contributor.localIdA02300-
dc.relation.journalcodeJ01762-
dc.identifier.eissn1096-9098-
dc.identifier.pmid16615154-
dc.identifier.urlhttp://onlinelibrary.wiley.com/doi/10.1002/jso.20336/abstract-
dc.subject.keywordestrogen receptor‐β-
dc.subject.keywordvariant-
dc.subject.keywordbreast cancer-
dc.subject.keywordcarcinogenesis-
dc.subject.keywordRT‐PCR-
dc.subject.keywordTP‐PCR-
dc.contributor.alternativeNameKim, Gwi Eon-
dc.contributor.alternativeNameKim, Seung Il-
dc.contributor.alternativeNameKim, Joo Hang-
dc.contributor.alternativeNamePark, Byeong Woo-
dc.contributor.alternativeNameYang, Woo Ick-
dc.contributor.affiliatedAuthorKim, Gwi Eon-
dc.contributor.affiliatedAuthorKim, Seung Il-
dc.contributor.affiliatedAuthorKim, Joo Hang-
dc.contributor.affiliatedAuthorPark, Byeong Woo-
dc.contributor.affiliatedAuthorYang, Woo Ick-
dc.rights.accessRightsnot free-
dc.citation.volume93-
dc.citation.number6-
dc.citation.startPage504-
dc.citation.endPage510-
dc.identifier.bibliographicCitationJOURNAL OF SURGICAL ONCOLOGY, Vol.93(6) : 504-510, 2006-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.